References
- Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, et al. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020;95(6):1222–1230.
- Guler AA, Tombul N, Yıldız PA, et al. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease. Scand J Clin and Lab Invest. 2021;81(2):160–165.
- Henry BM, Benoit S, Lippi G, et al. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): a preliminary report. Prog in Cardiovas Dis. 2020;63(5):702–703.
- Rieder M, Wirth L, Pollmeier L, et al. Serum ACE-2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19. Am J Hypertens. 2021;34(3):278–281.
- Henry BM, Benoit JL, Berger BA, et al. Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7. J Med Virol. 2021;93(2):678–680.
- Lippi G, Henry BM, Hoehn J, et al. Validation of the Corona-score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States. Clin Chem Lab Med. 2020;58(12):e311–e313.
- Benoit J, Benoit SW, Lippi G, et al. False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations. Diagnosis. 2020;7(4):405–407.
- Zambelli V, Bellani G, Borsa R, et al. Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome. Intensive Care Med Exp. 2015;3(1):44.
- Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374.
- Kutz A, Conen A, Gregoriano C, et al. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19. Eur J of Endocrinol. 2021;184(4):543–552.